Mutation of the APC tumor suppressor gene is believed to be a rate-limiting and necessary event in the development of most colorectal tumors, both inherited and sporadic. The APC gene product is a component of the WNT signaling pathway; its ability to interact with the down-regulate beta-catenin affects the expression of genes that are regulated by transcription factors of the TCF/LEF HMG domain family (Clevers and van de Wetering, 1997). Mutation of APC clearly alters the transcription profile of cells through increases in cytoplasmic and nuclear beta-catenin, indirectly activating such genes as c-myc that in turn promote cell growth (He et al., 1998). However, the role of APC in non-beta-catenin induced mechanisms of growth control and differentiation is unknown. Therefore, further functional characterization of APC and its gene product in normal and malignant cells is important for a complete understanding of how its disruption is associated with tumor formation. She has shown that introduction of the APC gene into colon carcinoma cancer cells suppresses tumorigenicity, prevents entry into S-phase of the cell cycle and increases apoptosis, and that baculovirus-expressed, full-length and smaller sections of APC can prevent DNA replication and induce apoptosis using transcriptionally silent in vitro systems. In addition, she has shown that APC is phosphorylated by the cyclin-dependent kinase p34 at M-phase of the cell cycle. She proposes that the APC tumor suppressor contributes to the control of cell growth and cell death independently of beta-catenin-induced transcription. The immediate goals of this proposal are to determine the mechanisms by which APC regulates the cell cycle and apoptosis, and to determine the functional significance of p34-mediated phosphorylation of APC. The long-term goals of this application are to elucidate the mechanisms and pathways through which APC functions and, by doing so, to contribute to the design of therapeutic interventions for the treatments of patients with cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063507-09
Application #
6607201
Study Section
Pathology B Study Section (PTHB)
Program Officer
Mohla, Suresh
Project Start
1994-12-13
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
9
Fiscal Year
2003
Total Cost
$275,400
Indirect Cost
Name
University of Cincinnati
Department
Genetics
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Hankey, William; Frankel, Wendy L; Groden, Joanna (2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev 37:159-172
Hankey, William; McIlhatton, Michael A; Ebede, Kenechi et al. (2018) Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients. Cancer Res 78:617-630
Hankey, William; Chen, Zhong; Bergman, Maxwell J et al. (2018) Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. Oncotarget 9:31214-31230
Mcilhatton, Michael A; Boivin, Gregory P; Groden, Joanna (2016) Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer. Biomed Res Int 2016:1414383
McIlhatton, Michael A; Murnan, Kevin; Carson, Daniel et al. (2015) Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis. Cancer Prev Res (Phila) 8:650-6
Perchiniak, Erin M; Groden, Joanna (2011) Mechanisms Regulating Microtubule Binding, DNA Replication, and Apoptosis are Controlled by the Intestinal Tumor Suppressor APC. Curr Colorectal Cancer Rep 7:145-151
Qian, Jiang; Perchiniak, Erin M; Sun, Kristine et al. (2010) The mitochondrial protein hTID-1 partners with the caspase-cleaved adenomatous polyposis cell tumor suppressor to facilitate apoptosis. Gastroenterology 138:1418-28
Qian, Jiang; Sarnaik, Amod A; Bonney, Tera M et al. (2008) The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus. Gastroenterology 135:152-62
Kaiser, Sergio; Park, Young-Kyu; Franklin, Jeffrey L et al. (2007) Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8:R131